Physician profile
Michael J Bauer
NPI 1346417086
$4,406,189.41
in general payments reported to CMS, 2019-2025
41 companies · $562K in 2025
The $562K reported for 2025 was more than what 99% of Blood Banking & Transfusion Medicine providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $573K · 2020: $618K · 2021: $682K · 2022: $666K · 2023: $552K · 2024: $753K · 2025: $562K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.6M · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $218K · Travel and Lodging: $33K · Food and Beverage: $73.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,614,839.06 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $218,417.00 |
| Travel and Lodging | $33,300.00 |
| Food and Beverage | $73.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $607,708.00 | 2019-2025 | Grafix |
| Elutia, INC. | $469,650.00 | 2019-2023 | |
| Integra Lifesciences Corporation | $450,500.00 | 2019-2025 | Biodfactor |
| Medtronic, INC. | $356,267.60 | 2021-2025 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Magnifuse Bone Graft |
| Medtronic USA, INC. | $315,000.00 | 2019-2020 | |
| Mimedx Group, INC. | $270,320.00 | 2024-2025 | Bovine Collagen |
| Allergan, INC. | $253,766.72 | 2021-2023 | |
| Cook Biotech Incorporated | $228,500.00 | 2019-2023 | |
| Human Regenerative Technologies | $165,000.00 | 2019-2022 | |
| Sequence Lifescience, INC | $164,500.00 | 2024 | |
| Stryker Corporation | $131,495.74 | 2019-2025 | Augment Injectable, Allograft, Allograft Bio-Implants |
| Abbvie INC. | $124,181.00 | 2023-2025 | |
| Biotissue Holdings INC. | $110,764.00 | 2021-2024 | |
| Orthofix Medical, INC. | $91,500.00 | 2023-2025 | Osteoballast, Strand Plus, Osteostrand |
| Globus Medical, INC. | $81,967.00 | 2019-2023 | Allocate |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Bauer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.